Journal of Medical Microbiology · 2017 · 14 citations · 21 references
Life SciencesMicrobiologyMolecular BiologyBacteriologyDiagnostic MicrobiologyMedical MicrobiologyDiagnostic BacteriologyMycobacterial DiagnosticsPulmonary TuberculosisTuberculosis DiagnosisTuberculosis Diagnostic TestingDiagnostic Marker DiscoveryMycobacterium Tuberculosis InfectionNon-tuberculous Mycobacterial InfectionsPulmonary Tuberculosis DiagnosisReference StrainsSpecies-specific IdentificationTuberculosis DiagnosticsTuberculosis Molecular Testing
PURPOSE: We explored the efficiency of Rv1458c, the gene encoding a putative ABC drug transporter specific for the Mycobacterium tuberculosis complex (MTBC), as a diagnostic marker. METHODOLOGY: A 190 bp region of Rv1458c and a 300 bp region of hsp65 were targeted in a novel duplex PCR assay and the results were compared with those for PCR restriction analysis(PRA) using the restriction enzymes NruI and BamHI. Species identification of a subset of the isolates (n=50) was confirmed by sequencing. Clinical isolates of M. tuberculosis (n=426) obtained from clinically suspected patients of pulmonary tuberculosis and mycobacterial (n=13) and non-mycobacterial (n=8) reference strains were included in the study. RESULTS: The duplex PCR assay correctly identified 320/426 isolates as MTBC and 106/426 isolates as non-tuberculous mycobacteria(NTM). The test was 100 % specific and sensitive when compared with NruI/BamHI PCR restriction analysis and highlighted the use of Rv1458c as a diagnostic marker for MTBC. CONCLUSION: The duplex PCR assay could be developed for use as a screening test to identify MTBC in clinical specimens in peripheral laboratories with limited resources.
21
Toïdi Adékambi, Michel Drancourt · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · 2004 · 313 citations
Life Sciences, Biology, Microbiology +15
A. McNabb, Diane Eisler, Kathy Adie et al. · Journal of Clinical Microbiology · 2004 · 220 citations · Full text